{"prompt": "['HEMATOLOGY', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Hyperfibrinogenemia', '> ULN to 600 mg/dL', '>', '600 mg/dL', '-', '> ULN to 6.0 g/L', '>', '6.0 g/L', '-', '-', 'Fibrin Split Product', '20 to 40 g/mL', '> 40 to 50 g/mL', '> 50 to 60 g/mL', '> 60 g/mL', '20 to 40 mg/L', '> 40 to 50 mg/L', '>', '50 to 60 mg/L', '> 60 mg/L', 'Prothrombin Time (PT)', '> 1.00 to 1.25 X ULN', '>', '1.25 to 1.50 X ULN', '>', '1.50 to 3.00 X ULN', '> 3.00 X ULN', 'International Normalized Ratio', '1.1 to 1.5 X ULN', '>1.5 to 2.0 x ULN', '>2.0 to 3.0 x ULN', '>3.0 x ULN', 'of prothrombin time (INR)', 'Activated Partial', 'Thromboplastin Time (APTT)', '> 1.00 to 1.66 X ULN', '> 1.66 to 2.33 X ULN', '> 2.33 to 3.00 X ULN', '> 3.00 X ULN', 'Methemoglobin', '5.0 to 10.0%', '>', '10.0 to 15.0%', '> 15.0 to 20.0%', '> 20.0%', 'CRI 15-05 Protocol 13SEP2017', 'Page 52']['CHEMISTRY', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Hyponatremia', '130 to <LLN mEq/L', '125 to < 130 mEq/L', '121 to < 125 mEq/L', '< 121 mEq/L', '130 to <LLN mmol/L', '125 to < 130 mmol/L', '121 to < 125 mmol/L', '< 121 mmol/L', 'Hypernatremia', '146 to 150 mEq/L', '> 150 to 154 mEq/L', '> 154 to 159 mEq/L', '> 159 mEq/L', '146 to 150 mmol/L', '> 150 to 154 mmol/L', '> 154 to 159 mmol/L', '> 159 mmol/L', 'Hypokalemia', '3.0 to 3.4 mEq/L', '2.5 to < 3.0 mEq/L', '2.0 to < 2.5 mEq/L', '< 2.0 mEq/L', '3.0 to 3.4 mmol/L', '2.5 to < 3.0 mmol/L', '2.0 to < 2.5 mmol/L', '< 2.0 mmol/L', 'Hyperkalemia', '5.6 to 6.0 mEq/L', '> 6.0 to 6.5 mEq/L', '> 6.5 to 7.0 mEq/L', '> 7.0 mEq/L', '5.6 to 6.0 mmol/L', '> 6.0 to 6.5 mmol/L', '> 6.5 to 7.0 mmol/L', '> 7.0 mmol/L', 'Hypoglycemia', 'Adult and Pediatric', '55 to 64 mg/dL', '40 to < 55 mg/dL', '30 to < 40 mg/dL', '< 30 mg/dL', '1 Month', '3.03 to 3.58 mmol/L', '2.20 to < 3.03 mmol/L', '1.64 to < 2.20 mmol/L', '< 1.64 mmol/L', 'Infant, < 1 Month', '50 to 54 mg/dL', '40 to < 50 mg/dL', '30 to < 40 mg/dL', '< 30 mg/dL', '2.8 to 3.0 mmol/L', '2.2 to < 2.8 mmol/L', '1.7 to < 2.2 mmol/L', '< 1.7 mmol/L', 'Hyperglycemia, Nonfasting', '116 to 160 mg/dL', '> 160 to 250 mg/dL', '> 250 to 500 mg/dL', '> 500 mg/dL', '6.42 to 8.91 mmol/L', '> 8.91 to 13.90 mmol/L', '> 13.90 to 27.79 mmol/L', '> 27.79 mmol/L', 'Hyperglycemia, Fasting', '110 to 125 mg/dL', '125 to 250 mg/dL', '250 to 500 mg/dL', '>500 mg/dL', '6.08 to 6.96 mmol/L', '>6.96 to 13.90 mmol/L', '>13.90 to 27.79 mmol/L', '>27.79 mmol/L', 'Hypocalcemia', '(corrected for albumin if', '7.8 to 8.4 mg/dL', '7.0 to < 7.8 mg/dL', '6.1 to < 7.0 mg/dL', '< 6.1 mg/dL', 'appropriate*)', '1.94 to 2.10 mmol/L', '1.74 to < 1.94 mmol/L', '1.51 to < 1.74 mmol/L', '< 1.51 mmol/L', 'Adult and Pediatric', '7 Days', 'Infant, < 7 Days', '6.5 to 7.5 mg/dL', '6.0 to < 6.5 mg/dL', '5.5 to < 6.0 mg/dL', '< 5.5 mg/dL', '1.61 to 1.88 mmol/L', '1.49 to < 1.61 mmol/L', '1.36 to < 1.49 mmol/L', '< 1.36 mmol/L', 'CRI 15-05 Protocol 13SEP2017', 'Page 53']\n\n###\n\n", "completion": "END"}